Loading insider details...
Latest Form 4 (Nov 14, 2026): Sale of 6,939 SEPN shares, $319.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 14, 2026 | Septerna, Inc. (SEPN) | Sale | 6,939 | $319.2K |
| Jul 2, 2026 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 32,000 | n/a |
| Jun 30, 2026 | Septerna, Inc. (SEPN) | Grant/Award | 15,000 | n/a |
| Jun 30, 2026 | Fulcrum Therapeutics, Inc. (FULC) | Sale | 18,000 | $65.6K |
| Jun 15, 2026 | Organon & Co. (OGN) | Grant/Award | 17,857 | $240.0K |
| Jun 30, 2025 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 36,000 | n/a |
| Jun 20, 2025 | Septerna, Inc. (SEPN) | Grant/Award | 16,623 | n/a |
| Jun 16, 2025 | Organon & Co. (OGN) | Grant/Award | 23,904 | $240.0K |
| Mar 10, 2025 | Septerna, Inc. (SEPN) | Purchase | 13,319 | $92.3K |
| Mar 7, 2025 | Septerna, Inc. (SEPN) | Purchase | 7,491 | $47.5K |